Phase II HRS-4642 Plus Chemotherapy With or Without Adebrelimab in KRAS G12D-Mutant Pancreatic Cancer: Preliminary Results at ESMO 2026 Oncodaily
Не только про женщин: что нужно знать каждому о профилактике рака молочной железы Твериград
Europe takes cancer science into immunology European Biotechnology Magazine
LAS VEGAS — Physicians can mitigate their legal risk by documenting their clinical reasoning and staying informed about emerging medical-legal issues, a speaker at OMED said. Medical legal “is always a great topic for people to learn more” about, John R. Casey, DO, MA, FACOEP-D, director of medical education at…
Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO STAT
Johnson & Johnson Reports Phase 1 Prostate Cancer Drug Results at ESMO 2026 Yahoo
The excitement around Moderna’s cancer vaccine is cooling. Here’s why. MarketWatch
Working During Cancer Treatment: Your FMLA and ADA Rights Cure Today
Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification. The findings come from almost eight years of follow-up in the academically led phase 3 PEACE-1 trial presented at the…
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника Lenta News
Обнаружен эффективный способ борьбы с распространенным видом рака кишечника Lenta News
ESMO 2026: Key Findings for Cancer Care and Drug Development, Upcoming Webinar Hosted by Xtalks PR Newswire
How Melanoma Became the Proving Ground for a Personalized Cancer Vaccine Bloomberg.com
New treatment approach shows promise in reducing prostate cancer spread McGill University
Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026, held in…